We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
751
Fiserv Inc
FISV
$27.7B
| $452K | 0.05% |
+5,120
| New | +$422K |
|
752
First Bancorp
FBP
$4.4B
| $450K | 0.05% |
39,248
-31,382
| -44% | -$331K |
|
753
Procter & Gamble
PG
$339B
| $450K | 0.05% |
+4,321
| New | +$421K |
|
754
Star Group
SGU
$424M
| $450K | 0.05% |
46,873
-3,119
| -6% | -$29.7K |
|
755
Malibu Boats
MBUU
$565M
| $449K | 0.05% |
11,345
-173
| -2% | -$7.16K |
|
|
AAIC
756
DELISTED
Arlington Asset Investment Corp.
AAIC
| $449K | 0.05% |
+56,373
| New | +$466K |
|
757
Upland Software
UPLD
$13.9M
| $447K | 0.05% |
1,055
-331
| -24% | -$113K |
|
|
FITB
758
Fifth Third Bancorp
FITB
$51.8B
| $446K | 0.05% |
+17,693
| New | +$471K |
|
|
CDR
759
DELISTED
Cedar Realty Trust, Inc
CDR
| $446K | 0.05% |
19,882
-5,783
| -23% | -$130K |
|
760
Graham Holdings Company
GHC
$4.99B
| $445K | 0.05% |
+652
| New | +$437K |
|
761
AAR Corp
AIR
$5.78B
| $443K | 0.04% |
+13,617
| New | +$493K |
|
762
Criteo S.A. Ordinary Shares
CRTO
$914M
| $443K | 0.04% |
+22,099
| New | +$563K |
|
|
ADSW
763
DELISTED
Advanced Disposal Services Inc
ADSW
| $443K | 0.04% |
15,811
-110
| -0.7% | -$2.86K |
|
|
TVPT
764
DELISTED
Travelport Worldwide Limited
TVPT
| $443K | 0.04% |
+28,148
| New | +$442K |
|
765
Opko Health
OPK
$1.03B
| $442K | 0.04% |
+169,173
| New | +$512K |
|
766
Vuzix
VUZI
$222M
| $442K | 0.04% |
+144,422
| New | +$579K |
|
767
Schneider National
SNDR
$6.32B
| $441K | 0.04% |
20,949
-167
| -0.8% | -$3.57K |
|
768
Simulations Plus
SLP
$370M
| $440K | 0.04% |
20,825
-1,600
| -7% | -$32K |
|
769
TE Connectivity
TEL
$62.6B
| $440K | 0.04% |
+5,451
| New | +$440K |
|
770
Tenable Holdings
TENB
$3.99B
| $440K | 0.04% |
13,903
+4,839
| +53% | +$137K |
|
|
CALY
771
Callaway Golf Company
CALY
$3.2B
| $439K | 0.04% |
27,584
+7,462
| +37% | +$123K |
|
772
Provident Financial Services
PFS
$3.21B
| $438K | 0.04% |
16,920
+6,521
| +63% | +$171K |
|
|
AMRS
773
DELISTED
Amyris Inc.
AMRS
| $438K | 0.04% |
209,548
+132,883
| +173% | +$524K |
|
774
Central Garden & Pet Co
CENT
$2.79B
| $437K | 0.04% |
+21,364
| New | +$569K |
|
775
PBF Energy
PBF
$7.43B
| $437K | 0.04% |
14,035
-25,131
| -64% | -$845K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.